CTOs on the Move

Zenflow

www.zenflow.com

 
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.zenflow.com
  • 395 Oyster Point Blvd Suite 501
    South San Francisco, CA USA 94080
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Zenflow raised $24.3M on 04/15/2021

Similar Companies

Powered by MRP

Powered by MRP wants to radically decrease healthcare cost with technology first solutions. Our commitment is to build the first digitally enabled end- to-end marketplace for Medical Aesthetic Professional. At Powered by MRP we focus on providing medical devices, resources, training, education and support to our customers to empower them to deliver top service to their clients. We are committed to a culture of collaboration where every voice is heard and understood. We believe in embracing diversity and that it brings better insight, solutions, and serves as the most intentional way to better our company. This supports our strategy, partnerships and collaboration to achieve being the most trusted Aesthetic Marketplace throughout the world.

Via Biomedical

Via Biomedical is a Osseo, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Silver Top Supply Limited

Silver Top Supply Limited is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MBF Capital Corporation

MBF Capital Corporation is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.